Snake Venom: From Deadly Toxins to Life-saving Therapeutics

Author(s): Humera Waheed*, Syed F. Moin, M. I. Choudhary

Journal Name: Current Medicinal Chemistry

Volume 24 , Issue 17 , 2017

  Journal Home
Translate in Chinese
Become EABM
Become Reviewer
Call for Editor


Snakes are fascinating creatures and have been residents of this planet well before ancient humans dwelled the earth. Venomous snakes have been a figure of fear, and cause notable mortality throughout the world. The venom constitutes families of proteins and peptides with various isoforms that make it a cocktail of diverse molecules. These biomolecules are responsible for the disturbance in fundamental physiological systems of the envenomed victim, leading to morbidity which can lead to death if left untreated. Researchers have turned these life-threatening toxins into life-saving therapeutics via technological advancements. Since the development of captopril, the first drug that was derived from bradykininpotentiating peptide of Bothrops jararaca, to the disintegrins that have potent activity against certain types of cancers, snake venom components have shown great potential for the development of lead compounds for new drugs. There is a continuous development of new drugs from snake venom for coagulopathy and hemostasis to anti-cancer agents. In this review, we have focused on different snake venom proteins / peptides derived drugs that are in clinical use or in developmental stages till to date. Also, some commonly used snake venom derived diagnostic tools along with the recent updates in this exciting field are discussed.

Keywords: Snake toxin, therapeutic agents, venom diagnostic tools, anti-coagulant agents, drug discovery and development, peptide drugs, pharmaceutical industry, fibrin sealant, omics technologies.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2017
Page: [1874 - 1891]
Pages: 18
DOI: 10.2174/0929867324666170605091546
Price: $65

Article Metrics

PDF: 159
HTML: 60
PRC: 2